On Friday, Orchestra BioMed Holdings Inc (NASDAQ: OBIO) opened higher 9.76% from the last session, before settling in for the closing price of $2.87. Price fluctuations for OBIO have ranged from $2.20 to $6.50 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -273.68% annually for the last half of the decade. Company’s average yearly earnings per share was noted -4.99% at the time writing. With a float of $42.06 million, this company’s outstanding shares have now reached $53.96 million.
Orchestra BioMed Holdings Inc (OBIO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Orchestra BioMed Holdings Inc is 22.05%, while institutional ownership is 34.92%. The most recent insider transaction that took place on Sep 19 ’25, was worth 2,450. In this transaction Director of this company bought 1,000 shares at a rate of $2.45, taking the stock ownership to the 108,482 shares. Before that another transaction happened on Aug 25 ’25, when Company’s Director bought 5,760 for $2.61, making the entire transaction worth $15,034. This insider now owns 71,709 shares in total.
Orchestra BioMed Holdings Inc (OBIO) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.41 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.44) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.51% during the next five years compared to -273.68% drop over the previous five years of trading.
Orchestra BioMed Holdings Inc (NASDAQ: OBIO) Trading Performance Indicators
Check out the current performance indicators for Orchestra BioMed Holdings Inc (OBIO). In the past quarter, the stock posted a quick ratio of 2.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 57.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.83, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.51 in one year’s time.
